Search
for
Sort by
Research 601–630 of 1000+
- Cosmeceutical and Dermatological Potential of Olive Mill Wastewater: A Sustainable and Eco-Friendly Source of Natural Ingredients
- Molecular Mechanisms of Hair Follicle Development
- Comprehensive Insight into Cutaneous Application of Hemp
- Rice Germ Oil and Ferulic Acid Effects on Hair
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Inhibitory influence of agmatine on catamenial-like seizure susceptibility in progesterone withdrawn female rats
- The Potential Role of Exosomes in Aesthetic Plastic Surgery: A Review of Current Literature
- Isolation, Structural Elucidation and Therapeutic Potentials of Root of Cucurbita pepo
- From Waste to Beauty: Agri-Food By-Products as Sources of Antioxidant Compounds for Cosmeceutical Applications
- Adenosine as an Active Ingredient in Topical Preparations Against Hair Loss: A Systematic Review and Meta-Analysis of Published Clinical Trials
- The vitamin B5/coenzyme A axis: A target for immunomodulation?
- Potensi Daun Katuk dalam Mencegah Kerontokan Rambut
- Peptidylarginine Deiminase Isoforms Are Differentially Expressed in the Anagen Hair Follicles and Other Human Skin Appendages
- Conventional and novel stem cell based therapies for androgenic alopecia
- Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review
- Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- Demethylation of methionine and keratin damage in human hair
- In Vitro and Ex Vivo Hair Follicle Models to Explore Therapeutic Options for Hair Regeneration
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Generating detailed intercellular communication patterns in psoriasis at the single-cell level using social networking, pattern recognition, and manifold learning methods to optimize treatment strategies
- Scientific opinion on the tolerable upper intake level for selenium
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- A nanocomposite competent to overcome solubility and permeation issues of capsaicin and thiocolchicoside simultaneously in gout management: Fabrication of nanocubosomes
- Physicochemical properties of wild and cultivated Saccharina latissima macroalgae harvested in the Canadian boreal-subarctic transition zone
- Spherical Skin Model: Stratified Co‐Culture of Fibroblasts and Keratinocytes on Spherical Beads Toward Compound Screening
- Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo
- ICP5249 Promotes Hair Growth by Activating the AMPK-Autophagy Signaling Pathway
- Senotherapeutic Potential of Araliadiol in Senescent Human Dermal Fibroblasts: An In Vitro Study Using Three Senescence Models